血液管理系统市场－全球产业规模、份额、趋势、机会和预测（按类型、最终用户、地区和竞争细分，2020-2030 年）

2024 年全球血液管理系统市场价值为 152.2 亿美元，预计到 2030 年将达到 235.6 亿美元，预测期内复合年增长率为 7.53%。由于外科手术数量的增加、创伤和慢性病发病率的上升以及对有效血液使用和输血安全的更加重视，市场正在经历强劲增长。随着全球人口老化以及心血管和癌症病例的激增，对可靠的血液管理系统的需求正在上升。医疗机构正在增加对减少血液浪费、改善库存控制和确保输血准确性的技术的投资。此外，优惠的报销政策和政府促进高效血液使用的努力正在促进市场成长。自动化、数位追踪和即时监控方面的进步正在重塑血液的采集、储存和管理方式，进一步推动全球医疗保健环境的需求。

关键市场驱动因素

血液和血液製品需求不断增长

主要市场挑战

实施和维护成本高

主要市场趋势

采用基于云端的血液管理解决方案

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球血液管理系统市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（捐赠者管理模组、输血服务模组、库存管理、捐赠计划、筛检和测试、报告和分析、整合和互通性、其他）
  • 按最终使用者（血库、医院、门诊护理中心等）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美血液管理系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲血液管理系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太血液管理系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲血液管理系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲血液管理系统市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Cerner Corporation
• Haemonetics Corporation
• Telvent GIT SA
• Terumo Corporation
• Fresenius SE & Co. KGaA
• Grifols, SA
• Baxter International Inc.
• Stryker Corporation
• Becton, Dickinson and Company
• Biolife Solutions, Inc.

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Blood Management System Market was valued at USD 15.22 Billion in 2024 and is projected to reach USD 23.56 Billion by 2030, growing at a CAGR of 7.53% during the forecast period. The market is experiencing strong growth driven by the increasing number of surgical procedures, rising incidence of trauma and chronic illnesses, and greater emphasis on effective blood usage and transfusion safety. With the aging global population and a surge in cardiovascular and cancer cases, demand for reliable blood management systems is on the rise. Healthcare institutions are increasingly investing in technologies that reduce blood wastage, improve inventory control, and ensure transfusion accuracy. Additionally, favorable reimbursement policies and government efforts aimed at promoting efficient blood use are enhancing market growth. Advancements in automation, digital tracking, and real-time monitoring are reshaping how blood is collected, stored, and administered, further fueling demand across global healthcare settings.

Key Market Drivers

Growing Demand for Blood and Blood Products

The surging demand for blood and related products continues to drive the growth of the global blood management system market. Medical treatments such as surgeries, cancer therapies, and organ transplants rely heavily on the availability of blood transfusions to enhance patient recovery. This increased need directly contributes to the adoption of advanced systems that enable efficient management of blood resources. For example, patients with sickle cell disease, which affects around 100,000 individuals in the United States, require lifelong blood transfusion support. Healthcare facilities are recognizing the importance of accurate tracking, storage, and usage of blood units, leading to greater adoption of blood management technologies to address growing demand and ensure optimal supply chain efficiency.

Key Market Challenges

High Implementation and Maintenance Costs

A significant challenge in the global blood management system market is the high cost associated with implementation and maintenance. The initial investment in acquiring sophisticated systems-including software, hardware, and infrastructure-can be substantial, often deterring smaller healthcare facilities or those in resource-constrained regions. Integration with existing hospital networks may require tailored solutions, increasing the overall expense. Additionally, these systems demand ongoing maintenance such as regular software updates, technical support, and calibration of advanced features like temperature monitoring and automated tracking. The need for specialized staff training and compliance with strict regulatory requirements further elevates operational costs, posing a barrier to broader market penetration.

Key Market Trends

Adoption of Cloud-Based Blood Management Solutions

The increasing adoption of cloud-based solutions is a transformative trend in the global blood management system market. Cloud platforms offer scalable, cost-effective alternatives to traditional on-premise systems, enabling seamless data storage, remote access, and enhanced collaboration among healthcare providers. This model reduces the need for expensive infrastructure while improving operational flexibility and data security. Cloud-based systems also support integration with Electronic Health Records (EHR), promoting real-time data sharing and improving transfusion accuracy and safety. This trend is especially advantageous for smaller facilities and institutions in emerging markets. As digital transformation becomes a strategic priority in healthcare, cloud adoption is expected to expand, facilitating more efficient and responsive blood supply chain management.

Key Market Players

• Cerner Corporation
• Haemonetics Corporation
• Telvent GIT S.A.
• Terumo Corporation
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Baxter International Inc.
• Stryker Corporation
• Becton, Dickinson and Company
• Biolife Solutions, Inc.

Report Scope

In this report, the Global Blood Management System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Management System Market, By Type:

• Donor Management Module
• Transfusion Service Module
• Inventory Management
• Donation Scheduling
• Screening & Testing
• Reporting & Analytics
• Integration & Interoperability
• Others

Blood Management System Market, By End User:

• Blood Banks
• Hospitals
• Ambulatory Care Centers
• Others

Blood Management System Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Management System Market.

Available Customizations

Global Blood Management System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Blood Management System Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Donor Management Module, Transfusion Service Module, Inventory Management, Donation Scheduling, Screening & Testing, Reporting & Analytics, Integration & Interoperability, Others)
  • 5.2.2. By End User (Blood Banks, Hospitals, Ambulatory Care Centers, Others)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Blood Management System Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Management System Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Mexico Blood Management System Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Canada Blood Management System Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe Blood Management System Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Blood Management System Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Germany Blood Management System Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Blood Management System Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Blood Management System Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Blood Management System Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Blood Management System Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Blood Management System Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Blood Management System Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. South Korea Blood Management System Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. Japan Blood Management System Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Blood Management System Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. South America Blood Management System Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Blood Management System Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Blood Management System Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Blood Management System Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Blood Management System Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Blood Management System Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Blood Management System Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Blood Management System Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Cerner Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Haemonetics Corporation
• 14.3. Telvent GIT S.A.
• 14.4. Terumo Corporation
• 14.5. Fresenius SE & Co. KGaA
• 14.6. Grifols, S.A.
• 14.7. Baxter International Inc.
• 14.8. Stryker Corporation
• 14.9. Becton, Dickinson and Company
• 14.10. Biolife Solutions, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer